| Period Ending | Jan 30, 2013 | Oct 30, 2012 | Jul 30, 2012 | Apr 29, 2012 |
|---|
|
Total Revenue
|
856,832
|
692,894
|
676,269
|
568,930
| | Cost of Revenue | 543,136 | 432,052 | 421,755 | 366,451 | | |
Gross Profit
|
313,696
|
260,842
|
254,514
|
202,479
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 181,774 | 167,332 | 158,576 | 149,564 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
131,922
|
93,510
|
95,938
|
52,915
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 716 | 128 | 144 | 299 |
|
Earnings Before Interest And Taxes | 132,638 | 93,638 | 96,082 | 53,214 |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | 132,638 | 93,638 | 96,082 | 53,214 |
|
Income Tax Expense | 50,090 | 34,121 | 34,790 | 19,257 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 82,548 | 59,517 | 61,292 | 33,957 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
82,548
|
59,517
|
61,292
|
33,957
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
82,548
|
59,517
|
61,292
|
33,957
|
|
1.74 (3.91%) 8:08AM EDT - Nasdaq Real Time Price